SCHEMBL4723773

SCHEMBL4723773

COc1ccc(C2OCCO2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.48
KDM1A O60341 2/20 0.48
MAOB P27338 1/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.43
DRD2 P14416 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
HTR2C P28335 1/20 0.42
MAPK1 P28482 1/20 0.41
ACHE P22303 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8155961 0.94 ESR2 (0.45) MAOAKDM1AMAOBCA12CA1
SCHEMBL9778992 0.92 KDM1A (0.46) MAOAKDM1AMAOBCA12CA1
SCHEMBL29950610 0.92 KDM1A (0.46) MAOAKDM1AMAOBCA12CA1
SCHEMBL31165268 0.89 MAPT (0.59) MAOAKDM1AMAOBNPC1RAB9A
SCHEMBL9778655 0.89 KDM4E (0.44) MAOAKDM1AMAOBMAPTDRD2
SCHEMBL19221186 0.87 MAOA (0.48) MAOAKDM1AMAOBCA12CA1
SCHEMBL11384551 0.83 KDM1A (0.46) MAOAKDM1AMAOBCA12CA1
SCHEMBL8200366 0.83 MAOA (0.46) MAOAKDM1AMAOBCA12CA1
SCHEMBL10452473 0.83 NPC1 (0.54) MAOAKDM1AMAOBCA12CA1
SCHEMBL9779134 0.82 KDM4E (0.45) MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108473484-A Compounds useful as TRPM8 modulators 赛诺米克斯公司 2018-08-31 CN disclosed
US-9585382-B2 Composition comprising a pesticide and an acetal solvent BASF SE (DE) 2017-03-07 US disclosed
US-9585382-B2 Composition comprising a pesticide and an acetal solvent BASF SE (DE) 2017-03-07 US disclosed
EP-3130587-A1 HYDROPHILIC POLYMER DERIVATIVE HAVING CYCLIC BENZYLIDENE ACETAL LINKER NOF Corporation (JP) 2017-02-15 EP disclosed
WO-2016159071-A1 BIODEGRADABLE POLYETHYLENE GLYCOL DERIVATIVE HAVING CYCLIC BENZYLIDENE ACETAL LINKER 日油株式会社 2016-10-06 WO disclosed
US-20150232616-A1 HYBRID BLOCK COPOLYMER MICELLES WITH MIXED STEREOCHEMISTRY FOR ENCAPSULATION OF HYDROPHOBIC AGENTS INTEZYNE TECHNOLOGIES, INC. 2015-08-20 US disclosed
EP-2701502-B1 COMPOSITION COMPRISING A PESTICIDE AND AN ACETALIC SOLVENT BASF SE (DE) 2015-08-05 EP disclosed
US-8980326-B2 Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents INTEZYNE TECHNOLOGIES, INC. (US) 2015-03-17 US disclosed
US-8779008-B2 Polymeric micelles for drug delivery INTEZYNE TECHNOLOGIES, INC. (US) 2014-07-15 US disclosed
EP-1807436-B1 HETEROBIFUNCTIONAL POLY(ETHYLENE GLYCOL) AND USES THEREOF INTEZYNE TECHNOLOGIES INC (US) 2014-06-18 EP disclosed
US-20110021718-A1 SYNTHESIS OF HYBRID BLOCK COPOLYMERS AND USES THEREOF INTEZYNE TECHNOLOGIES (US) 2011-01-27 US disclosed
US-20100075260-A1 PLATE MAKING METHOD OF LITHOGRAPHIC PRINTING PLATE PRECURSOR FUJIFILM CORPORATION (JP) 2010-03-25 US disclosed
US-20100075260-A1 PLATE MAKING METHOD OF LITHOGRAPHIC PRINTING PLATE PRECURSOR FUJIFILM CORPORATION (JP) 2010-03-25 US disclosed
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors PFIZER INC. 2008-07-24 US disclosed
EP-1874780-A1 4-PIPERAZINYLTHIENO[2,3-D]PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS Pharmacia & Upjohn Company LLC (US) 2008-01-09 EP disclosed
WO-2006100591-A1 4-PIPERAZINNYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-09-28 WO disclosed
EP-0210518-A2 Process for the preparation of o- and p-alkoxybenzaldehydes HAARMANN & REIMER GMBH (DE) 1987-02-04 EP disclosed
EP-0046307-B1 NOVEL URACIL DERIVATIVES, PROCESS FOR PREPARING THE SAME AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Chugai Seiyaku Kabushiki Kaisha (JP) 1984-11-21 EP disclosed
US-4415573-A ANTITUMOR AND ANTICARCINOGENIC AGENTS; REACTING A 1,3-DIOXOLANE AND A URACIL USING AN ACID CATALYST AND SOLVENT CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1983-11-15 US disclosed
EP-0046307-A1 Novel uracil derivatives, process for preparing the same and a pharmaceutical composition containing the same Chugai Seiyaku Kabushiki Kaisha (JP) 1982-02-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors TBXA2R, P2RY4, PF4 MAOA 559/4885KDM1A 3823/4885MAOB 517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.